AbbVie Exits CAR-T Cell Therapy Development Partnership With Caribou

Deal Snapshot: The companies had announced the deal back in February 2021, but citing its “strategic focus,” AbbVie told Caribou it was backing out.

• Source: Shutterstock

Who: AbbVie and Caribou Biosciences

What: Caribou said AbbVie had informed it that it would terminate the CAR-T cell therapy

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business